• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Non Compete Dead

Quote




This is not a concern here at Quest. Why would anyone want to leave such a great company to begin with?

Have you not heard it is one of the best companies to work for or did no one ever ask your opinion?
 




All the animals who like to post threatening messages about being sued if you go to another lab can now go crawl back under the rock they crawled out from under. Non-Competes are over across America.
 
















Non-competes don't affect sales reps in the lab industry unless your a higher up. Non-solicits are still in place. That didn't change. You leave you can't touch your business for a year. Industry standard. You don't seem to understand the difference between the two
 








anonymous said:
Non-competes don't affect sales reps in the lab industry unless your a higher up. Non-solicits are still in place. That didn't change. You leave you can't touch your business for a year. Industry standard. You don't seem to understand the difference between the two
Click to expand...
I'm not sure this is true. At least I don't remember reading this distinction in the FTC ruling. A non-solicit and non-disclosure, for example, are subsets of the Non-compete Agreement. I could see how the non-disclosure clause would withstand this ruling, since sharing proprietary information of an ex-employer would not impede an employee's ability to compete. However, a non-solicit would impede this ability, since in order to compete, an employee needs to be able to market a product/service to any potential client. This could be particularly obstructive to one's ability to compete if the prospect pool is limited to only a few competitors.
 








Top Bottom
Back
Quote